Mainstream medicine hasn’t yet found enough evidence-based treatments for long COVID. No wonder sufferers are turning to unproven therapies.
Research into the social dimensions of long Covid offers invaluable insights for its prevention, treatment and care.
What do disadvantaged communities need to weather long COVID? Ask them.
It’s estimated one in 10 people infected with SARS-CoV-2 will have lingering symptoms, but most people will improve over time.
A team from UNSW's Kirby Institute and St Vincent’s Hospital Sydney have uncovered an immune profile for long COVID, potentially paving the way for tailored treatment for those with ongoing symptoms.
Sufferers collected evidence of their persistent symptoms, and advocated for themselves and for further research. Even the term ‘long COVID’ stems from this activism.
One study suggests getting vaccinated halves the risk of developing long COVID.
A UNSW psychology researcher is behind neurocognitive testing recommendations that will help assess long COVID patients.
A major study led by UNSW medical researchers and NSW Health has tracked the recovery of nearly 3000 COVID-19 cases in NSW.
With over 139 million COVID-19 cases globally, the latest challenge for medical researchers is a post-COVID-19 syndrome referred to as 'long COVID'.